InnoPharm-2026 to Unite Global Leaders in Pharmaceutical Research and Innovation in Boston

BOSTON - April 20, 2026 - PRLog -- With just six months remaining, InnoPharm-2026 is set to bring together global leaders, researchers, and industry experts to explore the future of pharmaceutical research and development. Scheduled for November 2–4, 2026, in Boston, MA, the conference will serve as a premier platform for innovation, collaboration, and scientific exchange.

The 2nd Edition of InnoPharm will feature 70+ international speakers and a hybrid format, enabling both in-person and virtual participation. The program includes plenary sessions focused on breakthrough research and emerging trends in pharma R&D, along with keynote presentations covering artificial intelligence in drug discovery, precision medicine, biologics, and advanced therapeutics.

Renowned experts such as Donald E. Ingber, Paul A. Insel, Martin Schwartz, Rhoda Alani, Ruben Abagyan and many more will lead discussions on cutting-edge topics shaping the pharmaceutical landscape.

InnoPharm-2026 is designed to address real-world challenges in drug development, including rising R&D costs, high failure rates, and the need for faster, more efficient therapies. The conference will emphasize translational research, AI-driven innovation, and strategies to bridge the gap between laboratory discoveries and clinical application.

Call for Speakers, inviting researchers, scientists, and industry professionals worldwide to present their work and contribute to global scientific dialogue. Participants will gain opportunities to showcase research, build collaborations, and engage with leading experts across academia and industry.

InnoPharm aims to create a global ecosystem that accelerates innovation in pharmaceutical R&D and supports the development of next-generation therapies.

For more information and speaker submissions, visit:
https://pharm-science.com/